by Eric Christianson | May 21, 2025 | Infectious Disease and Oncology Case Studies
Nitrofurantoin is often used in patients for UTI prophylaxis. One potential concern with nitrofurantoin use is pulmonary toxicity. This can often be overlooked in patients as a potential cause of respiratory problems. Here’s a case scenario where nitrofurantoin...
by Eric Christianson | Jan 21, 2024 | Respiratory Medication and Disease State Clinical Pearls
There are so many inhalers on the market for asthma and COPD. LABA, LAMA, and ICS products are getting so hard to keep track of! Honestly, it gets a little overwhelming at times to remember them all by brand name and what category and classification they fall into. My...
by Eric Christianson | Mar 27, 2022 | Medication and Disease State Clinical Pearls For Pharmacists
COPD is a challenging disease that ultimately leads to a progressive reduction in lung function. Our mainstays of therapy are the bronchodilators like long-acting anticholinergic and long-acting beta-agonists. Roflumilast (podcast) is a unique medication for COPD in...
by Eric Christianson | Dec 13, 2013 | Cardiovascular Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
Elderly patient was on Amiodarone for treatment of chronic arrhythmia. Amiodarone has multiple clinical quirks and unique side effects associated with it. In my mind, it’s definitely a high risk/high reward type drug. The patient had begun to experience some shortness...
